Homepage
Medication Guide
What are the Indications for Gefapixant Tablets (Lifnua)?
Gefapixant Tablets (Lifnua) is a selective P2X3 receptor antagonist classified as a cough treatment medication. Launched in Japan in April 2022, it is primarily indicated for the treatment of refracto...
504
Thursday, November 27th, 2025, 10:49
What are the Purchase Channels for Gefapixant Tablets (Lifnua)?
Gefapixant Tablets (Lifnua) is a selective P2X3 receptor antagonist indicated for the treatment of refractory chronic cough. It has been marketed in Japan since April 2022. As a prescription drug, its...
502
Thursday, November 27th, 2025, 10:44
How to Use Sabril (Vigabatrin)
Sabril (vigabatrin) is an antiepileptic drug used to treat specific types of seizures, with vigabatrin as its main active ingredient.How to Use Sabril (Vigabatrin)Administration Route and Dosage Forms...
502
Thursday, November 27th, 2025, 10:40
Precautions for Inotuzumab ozogamicin (Besponsa) Administration
Inotuzumab ozogamicin (Besponsa) is a key therapeutic agent for relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia, exerting its therapeutic effect through precise targ...
502
Thursday, November 27th, 2025, 10:36
How to Use Ezetimibe (Zetia)
Ezetimibe (Zetia) is a selective cholesterol absorption inhibitor that effectively inhibits the absorption of dietary and biliary cholesterol by acting on the Niemann-Pick C1-Like 1 (NPC1L1) protein a...
503
Thursday, November 27th, 2025, 10:24
What is Ezetimibe (Zetia)?
Ezetimibe (Zetia) is a selective cholesterol absorption inhibitor that specifically inhibits the absorption of dietary and biliary cholesterol by acting on the brush border of the small intestine. App...
502
Thursday, November 27th, 2025, 10:02
How to Purchase Ezetimibe (Zetia)
Ezetimibe (Zetia) is a selective cholesterol absorption inhibitor that plays an important role in the treatment of dyslipidemias such as primary hyperlipidemia and homozygous familial sitosterolemia.H...
502
Thursday, November 27th, 2025, 09:49
What are the Side Effects of Inotuzumab ozogamicin (Besponsa)?
Inotuzumab ozogamicin (Besponsa) is an antibody-drug conjugate (ADC) targeting CD22, indicated for the treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (...
501
Thursday, November 27th, 2025, 09:22
How to Use Inotuzumab ozogamicin (Besponsa)
Inotuzumab ozogamicin (Besponsa) is an antibody-drug conjugate targeting CD22, specifically indicated for the treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leu...
503
Thursday, November 27th, 2025, 09:17
What is Inotuzumab ozogamicin (Besponsa)?
Inotuzumab ozogamicin (Besponsa) is an antibody-drug conjugate (ADC) targeting CD22. It achieves targeted elimination of cancer cells by precisely acting on the CD22 antigen expressed on the surface o...
501
Thursday, November 27th, 2025, 09:11
20 / 184
1837 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved